KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2025)

QuidelOrtho's Other Non-Current Liabilities history spans 4 years, with the latest figure at $138.7 million for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities rose 16.26% year-over-year to $138.7 million; the TTM value through Sep 2025 reached $138.7 million, up 16.26%, while the annual FY2024 figure was $55.3 million, 33.85% down from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $138.7 million at QuidelOrtho, up from $69.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $138.7 million in Q3 2025 and bottomed at $48.5 million in Q1 2022.
  • The 4-year median for Other Non-Current Liabilities is $77.0 million (2023), against an average of $84.0 million.
  • The largest annual shift saw Other Non-Current Liabilities crashed 33.85% in 2024 before it increased 16.26% in 2025.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $86.6 million in 2022, then decreased by 3.46% to $83.6 million in 2023, then tumbled by 33.85% to $55.3 million in 2024, then surged by 150.81% to $138.7 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Other Non-Current Liabilities are $138.7 million (Q3 2025), $69.8 million (Q1 2025), and $55.3 million (Q4 2024).